BOISE -- Idaho will receive more than $1 million as part of a near-record settlement over prescription drug misbranding.
The U.S. Justice Department today announced that Abbott Laboratories will pay a total of $1.5 billion in criminal and civil penalties for illegal promotion of the drug Depakote.
The FDA approved the drug for treatment of seizure disorders, bipolar disorder and prevention of migraines.
Abbott has pleaded guilty to charges of misbranding the drug and marketing it for uses that haven't been approved.
"The resolution of this case is a major accomplishment," said Deputy Attorney General James Cole. "The $1.5 billion that Abbott will pay is the second largest amount ever paid by a pharmaceutical company."
Idaho's share will go into the state's Consumer Protection Account.